Showing results (431-440 of 3,697) with videos related to
Sort By:
Pageof 370
International Journal of Clinical Oncology|December 11, 2013
Factors predicting incisional surgical site infection in patients undergoing open radical cystectomy for bladder cancerTatsuo Gondo, Yoshio Ohno, Jun Nakashima, et al.International Journal of Clinical Oncology|September 27, 2013
Prognostic value of regulatory T cells in newly diagnosed chronic myeloid leukemia patientsAsmaa M Zahran, Hosny Badrawy, Abeer IbrahimInternational Journal of Clinical Oncology|May 11, 2012
Treatment of bone metastases before the onset of painLuis Costa, Allan Lipton, Peyman Hadji, et al.International Journal of Clinical Oncology|August 29, 2016
Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significanceS Krishna Priya, Kishore Kumar, K R Hiran, et al.International Journal of Clinical Oncology|August 24, 2016
One-step nucleic acid amplification (OSNA): where do we go with it?Yasuhiro TamakiInternational Journal of Clinical Oncology|August 24, 2016
Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapyHiroki Ishihara, Takafumi Yagisawa, Tsunenori Kondo, et al.International Journal of Clinical Oncology|March 11, 2010
Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysisTakeshi Sakamoto, Hirofumi Yasui, Narikazu Boku, et al.International Journal of Clinical Oncology|March 12, 2010
Treatment of multiple keratoacanthomas with erlotinibDavid C Reid, Joan Guitart, Mark Agulnik, et al.International Journal of Clinical Oncology|March 3, 2010
Complete response of anaplastic pancreatic carcinoma to paclitaxel treatment selected by chemosensitivity testingTakeru Wakatsuki, Atsushi Irisawa, Hidemichi Imamura, et al.International Journal of Clinical Oncology|March 4, 2010
Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancerAkira Ono, Tateaki Naito, Haruyasu Murakami, et al.Pageof 370